Premium
Patient satisfaction after preservative free latanoprost; the PASSY survey in Germany
Author(s) -
ERB C
Publication year - 2014
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2014.t016.x
Subject(s) - latanoprost , medicine , glaucoma , epidemiology , ophthalmology , multicenter study , patient satisfaction , surgery , randomized controlled trial
Purpose To determine the characteristics and satisfaction regarding tolerance of glaucoma patients treated by Monoprost®, preservative‐free (PF) latanoprost, in ophthalmology consultations. Methods Multicenter, epidemiological, retrospective survey in 6 European countries. OHT/Glaucoma Patients treated by PF latanoprost for more than 2 months were included. A 2 page questionnaire recorded: ocular history, data on previous treatment, reason for change, tolerance of the treatments, OSD and tear substitutes use, eye examination. Results 248 patients from Germany were analyzed. Mean age was 67. 89.5 % of the patients had received another previous treatment and the reasons for previous changes were mainly local intolerance (66%) and insufficient efficacy (46%). 96 % of patients declared to be satisfied or very satisfied with their PF latanoprost treatment. Tolerance was declared as better or much better than their previous treatment by 79% of patients and the same by 17%. The use of Monoprost® UD in comparison to the previous treatment was easier for 40 % of the patients or the same for 52%. Within the 38% of patients who use tear substitutes, this use decreased for 28% and did not change for 66% of patients. Conclusion After 2 months of Monoprost® treatment, almost all the patients were satisfied of their treatment and more than three‐fourth considered that the tolerance was better than the previous treatment.Commercial interest